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Long-term Prognostic Value of
Dobutamine Stress Echocardiography in
Patients With Atrial Fibrillation*
Don Poldermans, MD; Jeroen J. Bax, MD; Abdou Elhendy, MD;
Fabiola Sozzi, MD; Eric Boersma, PhD; Ian R. Thomson, MD; and
Luc J. Jordaens, MD
Study objective: To assess the long-term prognostic value of dobutamine stress echocardiography
(DSE) for cardiac events (cardiac death, myocardial infarction, and late revascularization) in
patients with atrial fibrillation (AF).
Methods: Baseline ECGs were studied in patients undergoing DSE between 1989 and 1998.
Sixty-nine patients had AF before DSE. Prognostic value of DSE in these patients was compared
with a control group who had sinus rhythm (n 5 1,664). The presence of stress-induced ischemia
was noted for every patient. The mean follow-up period was 35 months (range, 6 to 84 months).
Data are presented as hazards ratio (HR) with 95% confidence interval (CI).
Results: Heart rate at rest was higher in patients with AF (77 6 15 beats/min vs 73 6 14 beats/min;
p 5 0.04); however, double product at peak stress was not different between patients with AF and
sinus rhythm (17,602 vs 17,169, respectively; p 5 0.46). In patients with AF, target heart rate was
achieved at a lower dobutamine dose (33 6 8 mg/kg/min vs 35 6 9 mg/kg/min; p 5 0.01). Cardiac
arrhythmias occurred more frequently (12% vs 5%; p 5 0.001) in patients with AF during DSE.
During a follow-up period of 7 years, cardiac death occurred in 5 patients, myocardial infarction
in 2 patients, and late revascularization in 10 patients. Prognostic value of DSE for all late cardiac
events was similar in patients with AF (HR, 3.0; 95% CI, 0.9 to 9.5) and sinus rhythm (HR, 3.4;
95% CI, 2.7 to 4.3; p 5 0.85).
Conclusion: The prognostic value of DSE for late cardiac events is maintained in patients with AF.
(CHEST 2001; 119:144–149)
Key words: atrial fibrillation; dobutamine stress echocardiography; long-term prognostic value
Abbreviations: AF 5 atrial fibrillation; CAD 5 coronary artery disease; CI 5 confidence interval; DSE 5 dobutamine
stress echocardiography; HR 5 hazards ratio; NWMA 5 new wall motion abnormalities
T he prevalence of atrial fibrillation (AF) increaseswith patient age and is about 5% in Americans
. 65 years old.1 AF is commonly associated with
heart disease; however, up to 30% of the patients
have no detectable organic heart disease (lone AF).1
Dobutamine stress echocardiography (DSE) is a
clinically useful method for evaluating presence and
prognosis of underlying coronary artery disease
(CAD), especially in patients with inadequate exer-
cise capacity due to noncardiac diseases like stroke or
claudication and in patients with preexisting ECG
abnormalities. However, certain factors may impair
the diagnostic accuracy of DSE in patients with AF.
These include unpredictable heart rate response and
side effects during dobutamine infusion. Addition-
ally, alteration of inotropic status between long and
short cycles may interfere with proper interpretation
of wall motion during stress. The test end point of
DSE is a maximal age- and gender-related heart rate
or signs of myocardial ischemia. In patients with AF,
infusion of the synthetic sympathomimetic agent
dobutamine may result in an increased atrioventric-
ular node conduction velocity and hence ventricular
rate.2 If heart rate is achieved at a lower dobutamine
infusion rate, compared to subjects with a sinus
rhythm, this may result in a reduced cardiac work-
load and sensitivity of the detection of CAD.3 Also,
dobutamine-induced cardiac arrhythmias may inter-
rupt the stress test prematurely.
Several studies have evaluated the prognostic
value of DSE for cardiac events during vascular
surgery,4 after acute myocardial infarction,5 and in
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patients with severe left ventricular dysfunction.6 We
have shown the high predictive value of DSE for
long-term cardiac events in a large group of pa-
tients.7 The principal purpose of this study was to
assess the prognostic value of DSE for late cardiac
events in patients with AF compared to patients with
sinus rhythm.
Materials and Methods
Patient Selection
We reviewed 2,500 DSE studies performed between 1989 and
1998 at the Thoraxcentre, Rotterdam, the Netherlands. Excluded
were patients in whom the test was used for evaluation of
interventional therapy. Of the remaining 1,733 patients, 69
patients (3.9%) had AF at the time of DSE. Sixty of these patients
were included in a previous analysis focusing specifically on
long-term outcome in relation to DSE results.7 However, the
impact of AF on prognosis in relation to DSE results has not been
addressed previously. The test was requested for diagnostic
reasons (63%) or preoperative cardiac risk evaluation (37%).
Follow-up was complete in all patients. Baseline clinical cardiac
risk factors are reported in Table 1. Patients who underwent
coronary revascularization within 3 months after DSE were
excluded from the analysis. In patients with sinus rhythm, this
occurred in 72 patients; in patients with AF, it occurred in 2
patients. In these patients, the decision to revascularize was
already made on clinical grounds and coronary angiography
results. The prognostic data from the remaining 67 patients with
AF and 1,592 patients in sinus rhythm are reported.
DSE
DSE was performed as previously described.4 b-Blocker med-
ication was not discontinued for the study. Two independent
investigators performed off-line assessment of echocardiographic
images. In the period 1989 to 1993, a 14-segment, 4-point score
was used8; after 1993, a 16-segment, 5-point score (1 5 normo-
kinesia, 2 5 mild hypokinesia, 3 5 severe hypokinesia, 4 5 aki-
nesia, and 5 5 dyskinesia) was used.9 Ischemia was defined as
worsening or new wall motion abnormalities (NWMA) during
stress, with the exception of akinesia becoming dyskinesia, which
was considered to be a mechanical phenomenon.10 For each
patient, the number of abnormal segments at rest were scored
and a wall motion score index (total score divided by the number
of assessable segments) was calculated at rest and during peak
stress based on the standard 14- or 16-segment model. The
intraobserver and interobserver agreement of the interpretation
of the echocardiographic images was 92% and 90%, respectively.
In case of disagreement between two observers, a third observer
resolved the dispute.
Follow-up
Follow-up data were obtained in 1998 for the period between
1993 and 1998. The mean period of follow-up was 35 months
(range, 6 to 84 months) after DSE. Physicians who were unaware
of patients’ stress test results assessed events. The present status
was determined by contacting the patient’s general physician
and/or review of the hospital records. The date of the last
interview or review was used to calculate the follow-up time.
Evaluated end points were death, myocardial infarction, and
coronary revascularization. Cardiac death was defined by clinical
data of acute myocardial infarction and/or significant cardiac
arrhythmias and/or refractory congestive heart failure, together
with ECG and autopsy studies when available. Elevations of
cardiac isoenzyme levels and development of new ECG changes
defined a nonfatal myocardial infarction. Revascularization by
coronary angioplasty or bypass surgery . 3 months after the
original DSE was considered to reflect new or progressive
symptoms. In patients with more than one cardiac event, the
worst event was chosen: documented cardiac death (worst),
nonfatal infarction (less worst), coronary revascularization (least
worst).
Statistical Analysis
Continuous variables are presented as mean 6 SD. Unpaired
Student’s t tests are applied to evaluate differences between
patients with sinus rhythm compared to those with AF. Dichot-
omous variables are presented as percentages; differences be-
tween groups are evaluated by x2 tests or Fisher’s Exact Tests, as
appropriate. To evaluate whether the prognostic value of DSE
was different in patients with sinus rhythm compared to those
with AF, interaction terms between DSE results (NWMA, rest
wall motion abnormalities, angina, and ST-segment changes
during DSE) and the baseline rhythm were added to Cox
proportional-hazards regression models predicting late cardiac
events. Separate hazard ratios (HRs) and 95% confidence inter-
vals (CIs) of DSE results were presented for patients with sinus
rhythm vs AF, whereas differences between the HR were
evaluated by x2 tests on the interaction terms. The probability of
the absence of cardiac events was calculated by the Kaplan-Meier
method. Log-rank tests were applied to compare event-free
survival between groups. The statistical significance of all tests
was stated at the 0.05 probability level.
Results
DSE
DSE results of patients with AF and sinus rhythm
(control group) are presented in Tables 2, 3. Patients
with AF receiving b-blocker therapy before the test
Table 1—Clinical Characteristics of Patients With AF
and Sinus Rhythm*
Characteristics
AF
(n 5 69)
Sinus Rhythm
(n 5 1,664)
p
Value
Mean (6 SD) age, yr 66.5 6 9.6 61.6 6 12 0.0001
Male gender 52 (75) 1177 (71) NS
Angina pectoris 9 (13) 401 (24) NS
Previous myocardial infarction 36 (52) 721 (43) NS
Diabetes mellitus 7 (10) 137 (8) NS
Hypertension 24 (34) 487 (29) NS
Hypercholesterolemia 5 (7) 235 (14) NS
Digoxin medication 10 (14) 73 (4) 0.001
b-blockers 10 (14) 370 (22) NS
ACE inhibitors 15 (21) 337 (21) NS
*Data are presented as No. (%) unless otherwise indicated.
ACE 5 angiotensin-converting enzyme; NS 5 not significant.
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required atropine more frequently (3 of 10 patients;
30%) than those who were not (4 of 59 patients; 7%;
p 5 0.008). Side effects of the test are presented in
Table 4. There were no myocardial infarctions or
fatal complications of the stress test.
Wide QRS-complex tachycardia, either short
(, 10 complexes) or sustained ($ 10 complexes),
occurred more frequently in patients with AF during
DSE compared to patients in sinus rhythm (12% vs
2%, respectively; p 5 0.001).
In patients with AF, there was no relation between
stress-induced ischemia and the occurrence of ar-
rhythmias or hypotension (decrease of systolic BP of
. 20 mm Hg). NWMA occurred in patients with and
without cardiac arrhythmias (6.5% vs 6.5%, respec-
tively; p 5 1.0) and in hypotensive patients (15.1% vs
16.9%, respectively) without hypotension (p 5 0.58).
Side effects caused a premature interruption of the
test in 7% in patients with AF vs 3% in patients with
a sinus rhythm (p 5 0.61).
Follow-up Results
The two patients who were referred for coronary
revascularization within 3 months after DSE had
stress-induced myocardial ischemia. Cardiac events
in patients with AF during follow-up were as follows:
documented cardiac death (n 5 5), nonfatal myocar-
dial infarction (n 5 2), and late coronary revascular-
ization (n 5 10).
Predictive Value of Clinical Data and DSE Results
In patients with AF, any cardiac event occurred in
15 of 67 patients (22.4%) during 4-year follow-up vs
367 of 1,592 patients (23.1%) in patients with sinus
rhythm (p 5 0.90). In Figure 1, the event-free sur-
vival of patients with and without NWMA of the two
different groups is presented. The annual cardiac
event rate of patients without NWMA in sinus
rhythm was 4.3% vs 4.0% in patients with AF. In
patients with NWMA, the annual cardiac event rate
was 9.3% in patients with sinus rhythm vs 10.3% in
patients with AF. A multivariable Cox model was
used to identify the predictive value for cardiac
events for stress test results. The significant results
for cardiac death or (re)infarction and all cardiac
events in patients with AF are presented in Fig 2, 3.
The HR of DSE results for the prediction of late
cardiac events was not significantly different be-
tween patients in sinus rhythm and AF. The stron-
Table 3—Dobutamine Stress Test Results of Patients With AF and Sinus Rhythm During DSE*
Variables AF (n 5 69) Sinus Rhythm (n 5 1,664) p Value
Mean dobutamine dose, mg/kg/min 33 6 8 35 6 9 0.01
Rest wall motion score index 1.39 6 0.41 1.33 6 0.46 NS
NWMA 19 (28) 538 (32) NS
ST segment ) changes 30 (44) 561 (34) NS
Angina during test 9 (13) 401 (24) 0.04
Test end point, %
Target heart rate 84 84 NS
Maximum dose dobutamine/atropine 4 6 NS
Signs of ischemia† 5 8 NS
Side effects 7 3 NS
*Data are presented as mean 6 SD or No. (%) unless otherwise indicated. See Table 1 legend for abbreviation.
†Signs of ischemia during dobutamine stress test: NWMA, angina, and ST-segment ) changes.
Table 4—Side Effects of DSE in Patients With AF and
Sinus Rhythm*
Side Effects AF, % Sinus Rhythm, % p Value
Hypotension 15.1 16.9 NS
Hypertension 0.19 0.20 NS
Arrhythmias 11.6 5.2 0.001
*Cardiac arrhythmias in patients with AF are defined as wide
QRS-complex tachycardia (short, , 10 complexes; sustained, $ 10
complexes). Cardiac arrhythmias in patients with sinus rhythm are
defined as AF, ventricular fibrillation, wide QRS-complex tachycar-
dia (short or sustained). Hypertension is defined as BP . 240/130
mm Hg. Hypotension is defined as a decrease of systolic BP of . 20
mm Hg. See Table 1 legend for abbreviation.
Table 2—Hemodynamic Data of Patients With AF and
Sinus Rhythm During DSE*
Variables
AF
(n 5 69)
Sinus rhythm
(n 5 1,664)
p
Value
Rest heart rate, beats/min 77 6 15 73 6 14 0.04
Peak heart rate, beats/min 126 6 19 125 6 21 NS
Rest systolic BP, mm Hg 137 6 23 136 6 24 NS
Peak systolic BP, mm Hg 140 6 29 139 6 30 NS
Rest diastolic BP, mm Hg 76 6 14 77 6 13 NS
Peak diastolic BP, mm Hg 73 6 16 72 6 16 NS
Double product at peak,
beats/min 3 mm Hg
17,169 17,550 NS
*Data are presented as mean 6 SD unless otherwise indicated. See
Table 1 legend for abbreviation.
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gest multivariable predictor for any cardiac event
was NWMA in patients with AF and in patients in
sinus rhythm (HR, 3.0; 95% CI, 0.9 to 9.5 vs HR, 3.4;
95% CI, 2.7 to 4.3; p 5 0.85).
Discussion
AF is a commonly encountered rhythm distur-
bance that increases with patient age. A substantial
number of patients with AF have underlying CAD.1
In these elderly patients, a nonexercise-dependent
stress test is useful to assess the presence, severity,
and prognosis of underlying CAD. This study
showed that AF did not influence the prognostic
value of DSE in a group of 67 patients compared to
a control group in sinus rhythm. The prognostic
value of NWMA during DSE for late cardiac events
was not significantly different compared to the con-
Figure 1. Kaplan-Meier curves for all cardiac events (cardiac death, infarction, and late revascular-
ization) during follow-up by results of DSE (with or without NWMA). Each plot represents the
cumulative percentage of patients (Pts.) remaining event free. There is a significant difference in
event-free survival in patients with NWMA compared to patients with a normal DSE, but no difference
between patients with AF and sinus rhythm.
Figure 2. Multivariable predictive value (HR and 95% CI) of DSE test results for late cardiac death
and myocardial infarction (MI). AP 5 angina pectoris; RWMA 5 rest wall motion abnormalities;
SR 5 sinus rhythm.
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trol group (HR, 3.0 [95% CI, 0.9 to 9.5] vs 3.4 [95%
CI, 2.7 to 4.3]; p 5 0.85). However, wide QRS-
complex tachycardia (short ventricular tachycardia or
aberration) was more frequent during DSE in pa-
tients with AF.
Heart rate at rest was higher in patients with AF
but was similar at peak stress. The double product at
peak stress (heart rate times systolic BP), represent-
ing myocardial workload, was also similar in both
groups. To achieve test end point, patients with AF
required significantly lower doses of dobutamine and
received atropine less often. However, this did not
influence the prognostic value.
As shown in previous studies,6 DSE has a high
prognostic value for late cardiac events in patients
with known or suspected CAD. This is related to the
“combined” information of DSE, which provides
information on left ventricular function at rest, func-
tional improvement at low-dose dobutamine in seg-
ments with rest dyssynergy, and the presence and
extent of myocardial ischemia. This study showed
that the chance of late cardiac events in patients with
AF was related with the presence and extent of CAD
and not the presence of AF. In patients without
NWMA, the chance of cardiac events during a 4-year
follow-up period was 4.0%, increasing to 10.3% in
patients with NWMA, similar to patients with sinus
rhythm.
Comparison With Previous Studies
The only study specifically evaluating the diagnos-
tic and prognostic value of DSE in patients with AF
was performed by Hobday et al.11 In a group of 92
patients, DSE was diagnostic for underlying CAD
(all 12 patients with NWMA had significant coronary
artery stenosis). During a follow-up period of
27 6 20 months, 54 patients without NWMA had no
cardiac events. In a group of 38 patients with
NWMA, 14 cardiac events occurred during follow-
up. The high prognostic value was confirmed by our
study. However, in contrast to our study during
DSE, no serious cardiac arrhythmias were noted.
Feasibility and Safety of Dobutamine-Atropine
Stress Echocardiography
DSE was highly feasible in patients with AF. The
test was inconclusive (ie, no target heart rate
achieved despite maximal dose dobutamine/atropine
or side effects interrupting the test) in 11% of the
patients. This was mostly due to cardiac arrhythmias
during DSE. The occurrence of wide QRS com-
plexes in patients with AF during dobutamine infu-
sion may represent aberrant ventricular conduction,
which tends to perpetuate itself, once a bundle
branch block occurred, or after a ventricular prema-
ture beat. Otherwise, it cannot be excluded that
short ventricular tachycardia was induced by AF.12–14
This caused a premature interruption of the test in
7%, without additional morbidity. This was not re-
lated to the induction of ischemia. In these patients,
vasodilator-induced stress, like dipyridamole, may be
preferred. So far, no study has directly studied the
diagnostic accuracy and safety in patients with AF
comparing dobutamine with dipyridamole.
Figure 3. Multivariable predictive value (HR and 95% CI) of DSE test results for all cardiac events.
See Figure 2 legends for abbreviations.
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Study Limitations
The study included a limited number of patients
with AF; during follow-up, only seven “hard cardiac
events” (cardiac death and MI) occurred. The lim-
ited number of patients with AF referred for testing
may be related to the fear of the referring physicians
for side effects, although not shown in any previous
study, during DSE. Also, the data are obtained in a
single center with a high volume and experience of
DSE. These results may not be achieved in less
“experienced” centers. However, major improve-
ments are expected in the echo quality, with the
introduction in the clinical area of second harmonic
imaging and contrast echocardiography.15,16
Conclusion
DSE has prognostic value for late cardiac events in
patients with AF during long-term follow-up. How-
ever, cardiac arrhythmias occur more frequently
compared to patients in sinus rhythm.
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